Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%)
< Home < Back

Natco Pharma launches Chlorantraniliprole 18.5% SC under Brand Name 'NATGEN'

Date: 26-09-2022

Natco Pharma has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in Indian Market. NATCO estimates the current market size of CTPR containing products in India to be over Rs 2000 crore.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.